This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet - Summary - MDSpire

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

Lilly moves to acquire Kelonia, plus gene therapy for deafness approved

  • April 27, 2026

  • 6 min

Share

Original Source(s)

This Week’s CGT News: Lilly’s $7B In Vivo CAR-T Bet

  • April 27, 2026

Related Content

Case review: adult epithelial type Wilms tumor in a 23-year-old female

RSV-infected children with mixed infections: clinical features and early predictive indicators of codetection with Streptococcus pneumoniae and Haemophilus influenzae

Global landscape analysis of antibody-drug conjugate clinical trials for prostatic neoplasms: current status, opportunities and challenges